compounded glp 1 lawsuit New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA issued 25 warning letters

Cigna Group stock (US1255231003): shares steady as company plans to end GLP-1 weight-loss coverage for employees Published on 06/03/2026 at 21:03 | Editorial responsibility: Rafael Mller, Editor-in-Chief AD HOC NEWS Cigna Group stock traded around the USD 272 mark on the New York Stock Exchange on Wednesday as investors digested news that the U.S

These temperature-sensitive injectable treatments for type 2 diabetes and weight management must be stored correctly, transported safely, and administered on schedule, even when crossing time zones

Trouble sleeping: If kratom is acting as a stimulant for you, it can make it harder to fall or to stay asleep

The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke